DAVID ZARIAN: Open Payments
NPI 1629179288 · ENCINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,102 in 134 payments from 27 companies in 2025. Trend: 2023 $2,566 · 2024 $2,220 · 2025 $3,102
Food & beverage: $3,102
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $491 |
| ABBVIE INC. | 20 | $435 |
| Amgen Inc. | 13 | $244 |
| GlaxoSmithKline, LLC. | 11 | $222 |
| Ardelyx, Inc. | 12 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $179 |
| Sumitomo Pharma America, Inc. | 11 | $139 |
| Corcept Therapeutics | 5 | $124 |
| Radius Health, Inc. | 4 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $110 |
Products named: BREZTRI, IBSRELA, TRELEGY ELLIPTA, JARDIANCE, VRAYLAR, LINZESS, GEMTESA, OTEZLA.
Industry payments across CA — which companies pay providers there.
